skip to content
Dovepress - Open Access to Scientific and Medical Research
View our mobile site

8852

Managing severe cancer pain: the role of transdermal buprenorphine: a systematic review

Review

(2976) Views  (597) Full article downloads

Authors: S Deandrea, O Corli, I Moschetti, et al

Published Date September 2009 Volume 2009:5 Pages 707 - 718
DOI: http://dx.doi.org/10.2147/TCRM.S4603

S Deandrea1,2, O Corli1, I Moschetti3, G Apolone1

1Center for the Evaluation and Research on Pain (CERP), Istituto di Ricerche Farmacologiche “Mario Negri”, Milan, Italy; 2Istituto di Statistica Medica e Biometria “GA Maccacaro”, Università degli studi di Milano, Milan, Italy; 3Italian Cochrane Center, Istituto di Ricerche Farmacologiche “Mario Negri”, Milan, Italy

Abstract: Pain is a frequent and important symptom in cancer patients. Among the available strong opioids, transdermal buprenorphine has been licensed in Europe since 2002, and results from a few clinical studies suggest that it may be a good alternative to the other oral or transdermal opioids. To assess the best available evidence on its efficacy and safety, we carried out a systematic literature review with the aim of pooling relevant studies. We identified 19 eligible papers describing 12 clinical studies (6 randomized controlled trials and 6 observational prospective studies), including a total of about 5000 cancer patients. Given the poor quality of reports and the heterogeneity of methods and outcomes, pooling was not feasible as the type of data was not appropriate for combining the results statistically. A meta-analysis based on individual data is ongoing in the context of the Cochrane Collaboration. In conclusion, although the narrative appraisal of each study suggests a positive risk benefit profile, well designed and statistically powered controlled clinical trials are needed to confirm this preliminary evidence.

Keywords: systematic review, transdermal buprenorphine, cancer pain








Readers of this article also read:

Pegylated liposomal doxorubicin in ovarian cancer
Comparison of linear–stochastic and nonlinear–deterministic algorithms in the analysis of 15-minute clinical ECGs to predict risk of arrhythmic death
Incretin-based therapies: new treatments for type 2 diabetes in the new millennium
Alglucosidase alfa: Long term use in the treatment of patients with Pompe disease
Five-year alendronate treatment outcome in older postmenopausal Japanese women with osteoporosis or osteopenia and clinical risk factors for fractures
Safety and efficacy of telbivudine for the treatment of chronic hepatitis B
Antimicrobial prophylaxis in colorectal surgery: focus on ertapenem
Lasofoxifene for the prevention and treatment of postmenopausal osteoporosis
"Globalized public health.” A transdisciplinary comprehensive framework for analyzing contemporary globalization’s influences on the field of public health
Exercise-induced bronchoconstriction: The effects of montelukast, a leukotriene receptor antagonist